David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 8,556 shares at $59.43 ($508K) on 2025-02-04, disclosed to the SEC on 2025-02-04.
Open-market sale of $508k RYTM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.43 | 4,278 | $254K | 50.0% |
| 2 | $59.43 | 4,278 | $254K | 50.0% |
| Total | $59.43 avg | 8,556 | $508K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |
| RYTM | SELL | 2024-03-19 | $3.6M | — | Filing → |